929 related articles for article (PubMed ID: 21324198)
1. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.
Koch A; Voigt S; Kruschinski C; Sanson E; Dückers H; Horn A; Yagmur E; Zimmermann H; Trautwein C; Tacke F
Crit Care; 2011; 15(1):R63. PubMed ID: 21324198
[TBL] [Abstract][Full Text] [Related]
2. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.
Donadello K; Scolletta S; Taccone FS; Covajes C; Santonocito C; Cortes DO; Grazulyte D; Gottin L; Vincent JL
J Crit Care; 2014 Feb; 29(1):144-9. PubMed ID: 24120089
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients.
Koch A; Voigt S; Sanson E; Dückers H; Horn A; Zimmermann HW; Trautwein C; Tacke F
Crit Care; 2011; 15(1):R45. PubMed ID: 21281508
[TBL] [Abstract][Full Text] [Related]
4. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
El-Mekkawy MS; Saleh NY; Sonbol AA
Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils are a main source of circulating suPAR predicting outcome in critical illness.
Gussen H; Hohlstein P; Bartneck M; Warzecha KT; Buendgens L; Luedde T; Trautwein C; Koch A; Tacke F
J Intensive Care; 2019; 7():26. PubMed ID: 31061709
[TBL] [Abstract][Full Text] [Related]
7. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.
Suberviola B; Castellanos-Ortega A; Ruiz Ruiz A; Lopez-Hoyos M; Santibañez M
Intensive Care Med; 2013 Nov; 39(11):1945-52. PubMed ID: 23949703
[TBL] [Abstract][Full Text] [Related]
8. Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
Reisinger AC; Niedrist T; Posch F; Hatzl S; Hackl G; Prattes J; Schilcher G; Meißl AM; Raggam RB; Herrmann M; Eller P
Sci Rep; 2021 Sep; 11(1):17476. PubMed ID: 34471146
[TBL] [Abstract][Full Text] [Related]
9. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
[TBL] [Abstract][Full Text] [Related]
10. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.
Koch A; Gressner OA; Sanson E; Tacke F; Trautwein C
Crit Care; 2009; 13(3):R95. PubMed ID: 19545363
[TBL] [Abstract][Full Text] [Related]
11. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
12. suPAR as a marker of infection in acute kidney injury - a prospective observational study.
Hall A; Crichton S; Varrier M; Bear DE; Ostermann M
BMC Nephrol; 2018 Aug; 19(1):191. PubMed ID: 30071826
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review.
Backes Y; van der Sluijs KF; Mackie DP; Tacke F; Koch A; Tenhunen JJ; Schultz MJ
Intensive Care Med; 2012 Sep; 38(9):1418-28. PubMed ID: 22706919
[TBL] [Abstract][Full Text] [Related]
14. Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation.
Koch A; Weiskirchen R; Sanson E; Zimmermann HW; Voigt S; Dückers H; Trautwein C; Tacke F
Crit Care; 2010; 14(5):R179. PubMed ID: 20932285
[TBL] [Abstract][Full Text] [Related]
15. Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis.
Koch A; Sanson E; Helm A; Voigt S; Trautwein C; Tacke F
Crit Care; 2010; 14(3):R94. PubMed ID: 20500817
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile.
Tsirigotis P; Chondropoulos S; Frantzeskaki F; Stamouli M; Gkirkas K; Bartzeliotou A; Papanikolaou N; Atta M; Papassotiriou I; Dimitriadis G; Dimopoulou I
J Crit Care; 2016 Apr; 32():9-15. PubMed ID: 26726794
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study.
Liu X; Shen Y; Li Z; Fei A; Wang H; Ge Q; Pan S
BMC Anesthesiol; 2016 Jul; 16(1):46. PubMed ID: 27473112
[TBL] [Abstract][Full Text] [Related]
18. Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients.
Koch A; Weiskirchen R; Kunze J; Dückers H; Bruensing J; Buendgens L; Matthes M; Luedde T; Trautwein C; Tacke F
J Crit Care; 2013 Dec; 28(6):947-53. PubMed ID: 23953490
[TBL] [Abstract][Full Text] [Related]
19. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
[TBL] [Abstract][Full Text] [Related]
20. Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?
Sunnetcioglu A; Sunnetcioglu M; Adıyaman F; Binici I; Soyoral L
Clin Respir J; 2017 Nov; 11(6):925-930. PubMed ID: 26683264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
